Latest Posts
About This Stock
More About This Stock
Watch
Watch
Read
Which Is A Better Investment? Amgen Vs Bristol-Myers Squibb… The Winner May Surprise You
Video By:
Jason Fieber
Wednesday, June 23, 2021 11:04 AM EDT
Both companies have the same yield, at right about 2.9%. They've also both been increasing their dividends for almost the same exact length of time - 12 years for Bristol-Myers Squibb versus 11 years for Amgen.
FV This Stock Should Be On Your Radar: It’s Selling At A 10% Discount And Rated A “Buy”
Video By:
Jason Fieber
Monday, June 21, 2021 9:55 AM EDT
There’s a common misperception among investors. This misperception is that you have to look far and wide for great long-term investment ideas. It’s as if blue-chip companies that are household names can’t continue to do well over the long run.
In this video: AMGN
3 Promising Oncology Stocks To Consider Adding To Your Portfolio
Article By:
StockNews
Monday, June 14, 2021 12:31 AM EDT
With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio.
July 2017 Stock Considerations
I read that #Repatha sales for this quarter are down significantly so be careful with $AMGN.